FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

61 letters match. Newest first.

  1. US Specialty Formulations, LLC

    US Specialty Formulations, a drug compounder registered as an outsourcing facility, made sterile compounded drugs under insanitary conditions.

    High risk
  2. Iso-Tex Diagnostics, Inc.

    FDA warns Iso-Tex Diagnostics over manufacturing violations that risk contamination of sterile radiopharmaceutical drugs.

    High risk
  3. Pharmacy Plus, Inc., dba Vital Care Compounder

    FDA warned Pharmacy Plus (Vital Care Compounder) that its sterile compounded drugs were made under insanitary conditions, risking contamination.

    High risk
  4. ImprimisRx NJ

    FDA found insanitary sterile compounding and subpotent timolol-latanoprost eye drops at ImprimisRx NJ.

    High risk
  5. New England Life Care, Inc. dba Advanced Compounding Solutions

    FDA cites Advanced Compounding Solutions for insanitary sterile-drug production and CGMP failures after a 2022 inspection.

    High risk
  6. North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding

    FarmaKeio, a Texas compounding pharmacy, made sterile drugs under insanitary conditions that put patients at risk.

    High risk
  7. Vita Pharmacy, LLC dba Talon Pharmacy of Boerne

    FDA warned Talon Pharmacy of Boerne that it made sterile compounded drugs under insanitary conditions that could contaminate them.

    High risk
  8. CardioQuip, LLC

    CardioQuip sold significantly modified cardiac heater-cooler devices without required FDA clearance and with quality system violations.

    High risk
  9. MasterPharm LLC

    FDA warned MasterPharm over compounded Finasteride Plus capsules with excess finasteride, undeclared minoxidil, and insanitary aseptic conditions.

    High risk
  10. Joe Wise Pharmacy, Inc., dba Wise Pharmacy

    FDA warned Wise Pharmacy that its compounded sterile and non-sterile drugs were adulterated by insanitary compounding conditions.

    High risk
  11. Hawaii Health Systems Corporation dba Kona Community Hospital Pharmacy

    Kona Community Hospital Pharmacy prepared sterile drugs in insanitary conditions with microbial contamination and facility flaws.

    High risk